Site Overlay

Combined treatment gamma knife radiosurgery and immunotherapy in a patient with brain metastases from malignant melanoma

By Борис Попщерев

Volume 12, Issue 1

Original Article / Published: December 2024

DOI:

M. Cholakova, K. Zhelev, M. Mihaylova – Hristova

Department of Radiotherapy and Radiosurgery, Heart and Brain Center of Clinical Excellence – Pleven; Department of Nuclear Medicine, USHATO “Prof. Ivan Tzernozemsky”– Sofia

Abstract

Melanoma is a complex disease with a high propensity for brain metastatic spread. Gamma Knife radiosurgery (GKRS) is a minimally invasive procedure to treat intracranial metastasis with a high rate of local tumor control. In this report, we describe the ongoing management of a patient with the development of brain metastases that required GKRS procedures for a total of 17 brain metastases receiving concurrent immunotherapy with pembrolizumab. The first imaging of the patient showed better local control after GKRS. Combined management with immunotherapy and GKRS for brain metastases resulted in extended survival while preserving neurological function and reducing adverse treatment effects in a patient with advanced metastatic brain melanoma.

References

  1. Siegel RL, Miller KD, Fuchs HE, Jemal A: Cancer statistics, 2021. CA Cancer J Clin. 2021, 71:7-33. 10.3322/caac.21654
  2. Bian SX, Routman D, Liu J, et al.: Prognostic factors for melanoma brain metastases treated with stereotactic radiosurgery. J Neurosurg. 2016, 125:31-39. 10.3171/2016.8.GKS161359
  3. Fife KM, Colman MH, Stevens GN, et al.: Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004, 22:1293-1300. 10.1200/JCO.2004.08.140
  4. Bowden G, Faramand A, Niranjan A, Lunsford LD, Monaco E 3rd: Gamma knife radiosurgery for the management of more than 15 cerebral metastases. World Neurosurg. 2019, 126:989-997. 10.1016/j.wneu.2019.03.019
  5. Hodi FS, O’Day SJ, McDermott DF, et al.: Improved survival with ipilimumab in patients with metastatic melanoma. Engl J Med. 2010, 363:711-723. 10.1056/NEJMoa1003466
  6. White RJ, Abel S, Horne ZD, et al.: Melanoma brain metastases: is it time to eliminate radiotherapy?. J Neurooncol. 2020, 149:27-33. 10.1007/s11060-020-03485-w
  7. Lesueur P, Lequesne J, Barraux V, et al.: Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer). Radiat Oncol. 2018, 13:138. 10.1186/s13014- 018-1083-1
  8. Wei Z, Niranjan A, Abou-Al-Shaar H, Deng H, Albano L, Lunsford LD: A volume matched comparison of survival after radiosurgery in non-small cell lung cancer patients with one versus more than twenty brain metastases. J Neurooncol. 2022, 157:417-423. 10.1007/s11060-022-03981-1
  9. Lippitz B, Lindquist C, Paddick I, Peterson D, O’Neill K,Beaney R: Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev. 2014, 40:48-59. 10.1016/j.ctrv.2013.05.002
  10. Grandhi R, Kondziolka D, Panczykowski D, et al.: Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases. J Neurosurg. 2012, 117:237-245.10.3171/2012.4.JNS11870
  11. Redmond KJ, Gui C, Benedict S, et al.: Tumor control probability of radiosurgery and fractionated stereotactic radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2021, 110:53-67. 10.1016/j.ijrobp.2020.10.034
  12. Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC: Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg. 1993, 79:661-666. 10.3171/jns.1993.79.5.0661
  13. Brown PD, Jaeckle K, Ballman KV, et al.: Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA. 2016,316:401-409. 10.1001/jama.2016.9839
  14. Yamamoto M, Serizawa T, Shuto T, et al.: Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol. 2014, 15:387-395. 10.1016/S1470-2045(14)70061-0
  15. Frakes JM, Figura NB, Ahmed KA, et al.: Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. J Neurosurg. 2015, 123:1261-1267. 10.3171/2014.12. JNS141919
  16. Serizawa T, Yamamoto M, Sato Y, et al.: Gamma Knife surgery as sole treatment for multiple brain metastases:2-center retrospective review of 1508 cases meeting the inclusion criteria of the JLGK0901 multi-institutional prospective study. J Neurosurg. 2010, 113:48-52. 10.3171/2010.8.GKS10838
  17. Yamamoto M, Kawabe T, Sato Y, Higuchi Y, Nariai T, Watanabe S, Kasuya H: Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors. J Neurosurg. 2014, 121:16-25. 10.3171/2014.8.GKS141421
  18. Luther N, Kondziolka D, Kano H, Mousavi SH, Flickinger JC,Lunsford LD: Motor function after stereotactic radiosurgery for brain metastases in the region of the motor cortex. J Neurosurg. 2013, 119:683 688.10.3171/2013.6.JNS122081
  19. Tawbi HA, Forsyth PA, Algazi A, et al.: Combined nivolumab and ipilimumab in melanoma metastatic to the brain. N Engl J Med. 2018, 379:722-730. 10.1056/NEJMoa1805453
  20. Niranjan A, Lunsford LD, Ahluwalia MS: Targeted therapies for brain metastases. Prog Neurol Surg. 2019, 34:125-137. 10.1159/000493057
Volume 11, Issue 1
Article [pdf]

Keywords:

melanoma, Gamma Knife, radiosurgery

How to cite this article:

M. Cholakova, K. Zhelev, M. Mihaylova–Hristova Combined treatment gamma knife radiosurgery and immunotherapy in a patient with brain metastases from malignant melanoma; Endourology and minimally invasive surgery, 2024; 12(1): 59-63

Corresponding author:

Kiril Zhelev Zhelev, MD, PhD

Adress: 2 Pierre Curie, str., Pleven, 5800, Bulgaria
e-mail: k_zhelev_@abv.bg; Tel: +359884741137